Loading...
Documents
-
B. Cuer, C. Mollevi, A. Anota, E. Charton, B. Juzyna, et al.. Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17. BMC Medical Research Methodology, 2020, 20 (1), pp.223. ⟨10.1186/s12874-020-01104-w⟩. ⟨hal-03696198⟩
-
Valérie Glorian, Jennifer Allègre, Jean Berthelet, Baptiste Dumetier, Pierre-Marie Boutanquoi, et al.. DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues.. Cell Death and Disease, 2017, 8 (5), pp.e2816. ⟨10.1038/cddis.2017.222⟩. ⟨hal-01542105⟩
-
Marc-Olivier Fischer, Pierre-Grégoire Guinot, Stéphane Debroczi, Pierre Huette, Christophe Beyls, et al.. Individualised or liberal red blood cell transfusion after cardiac surgery: a randomised controlled trial. British Journal of Anaesthesia, 2022, 128 (1), pp.37-44. ⟨10.1016/j.bja.2021.09.037⟩. ⟨hal-03572333⟩
-
S. Prévot, I. Dygaï-Cochet, J.M. Riedinger, J.M. Vrigneaud, L. Lavergnas, et al.. Démarche d’optimisation des modalités de gestion des déchets lors des traitements au 177Lu-oxodotréotide (Lutathera®). Médecine Nucléaire - Imagerie Fonctionnelle et Métabolique, 2021, 45 (5-6), pp.263-270. ⟨10.1016/j.mednuc.2021.06.144⟩. ⟨hal-03611637⟩